Results 1-11 of 11 (Search time: 0.002 seconds).
Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link | |
---|---|---|---|---|---|---|---|
1 | 2022 | Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B | Hu, HH; Jeng, WJ; Pan, MH; Luo, WS; Chang, CL; Huang, YT ; Su, CY; Chiang, CT; Jen, CL; Chien, YC; Lu, SN; Wang, LY; Huang, LR; Lee, MH; Liu, J; Nguyen, MH; Chen, CJ ; Yang, HI | ALIMENTARY PHARMACOLOGY & THERAPEUTICS 55(5), 558-567 | |||
2 | 2022 | G-Computation to Causal Mediation Analysis With Sequential Multiple Mediators-Investigating the Vulnerable Time Window of HBV Activity for the Mechanism of HCV Induced Hepatocellular Carcinoma | Tai, AS; Huang, YT ; Yang, HI ; Lan, LV; Lin, SH | Frontiers in public health 9, 757942 | |||
3 | 2022 | The association between sPD-1 levels versus liver biochemistry and viral markers in chronic hepatitis B patients: a comparative study of different sPD-1 assays | Jeng, Wen-Juei; Chen, Chien-Hung; Wang, Yi-Wen; Pan, Mei-Hung; Lin, Chia-Wei; Lin, Chun-Yen; Yang, Hwai-I | Virology Journal 19, 590 | |||
4 | 2022 | Letter: sPD-1 as a predictor for HBsAg seroclearance—shed light on inactive carriers with chronic hepatitis B. Authors' reply | Wen-Juei Jeng; Mei-Hung Pan; Hwai-I Yang | ALIMENTARY PHARMACOLOGY & THERAPEUTICS 55(8), 1057-1058 | |||
5 | 2022 | Serum soluble programmed death-1 levels predict the spontaneous HBeAg seroclearance in chronic hepatitis B | Chu, YJ; Jeng, WJ; Pan, MH; Hu, HH; Luo, WS; Su, CY; Chiang, CT; Jen, CL; Chen, CJ ; Yang, HI | Journal of Gastroenterology 57, 423-432 | |||
6 | 2022 | A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off-therapy relapse: An observational study | Peng, CW; Jeng, WJ; Yang, HI ; Liu, YC; Chien, RN; Liaw, YF | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 37(11), 2164-2172 | |||
7 | 2022 | Taiwan Biobank: A rich biomedical research database of the Taiwanese population | Feng, YA; Chen, CY; Chen, TT; Kuo, PH; Hsu, YH; Yang, HI ; Chen, WJ; Su, MW; Chu, HW; Shen, CY ; Ge, T; Huang, H; Lin, YF | Cell Genomics 2(11), 100197 | |||
8 | 2022 | Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort | Argirion, I; Brown, J; Jackson, S; Pfeiffer, RM; Lam, TK; O'Brien, TR; Yu, KJ; McGlynn, KA; Petrick, JL; Pinto, LA; Chen, CJ ; Hildesheim, A; Yang, HI ; Lee, MH; Koshiol, J | Cancers 14(21), 5280 | |||
9 | 2022 | Comparative performance of 14 HCC prediction models in CHB: a dynamic validation at serial on-treatment timepoints | Wu, S; Zhou, J; Wu, X; Sun, Y; Wang, B; Kong, Y; Zhan, S; Jia, J; Yang, HI ; You, H | AMERICAN JOURNAL OF GASTROENTEROLOGY 117(9), 1444-1453 | |||
10 | 2022 | Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine | Park, J; Le, AK; Tseng, TC; Yeh, ML; Jun, DW; Trinh, H; Wong, GLH; Chen, CH; Peng, CY; Kim, SE; Oh, H; Kwak, MS; Cheung, KS; Toyoda, H; Hsu, YC; Jeong, JY; Yoon, EL; Ungtrakul, T; Zhang, J; Xie, Q; Ahn, SB; Enomoto, M; Shim, JJ; Cunningham, C; Jeong, SW; Cho, YK; Ogawa, E; Huang, R; Lee, DH; Takahashi, H; Tsai, PC; Huang, CF; Dai, CY; Tseng, CH; Yasuda, S; Kozuka, R; Li, J; Wong, C; Wong, CC; Zhao, C; Hoang, J; Eguchi, Y; Wu, C; Tanaka, Y; Gane, E; Tanwandee, T; Cheung, R; Yuen, MF; Lee, HS; Yu, ML; Kao, JH; Yang, HI ; Nguyen, MH | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20(4), 874-885.e4 | |||
11 | 2022 | Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection | Wu, HC; Jeng, WJ; Pan, MH; Hsieh, YC; Lu, SN; Chen, CJ ; Yang, HI | JHEP reports : innovation in hepatology 4(2), 100410 |